Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tomas Ganz
University of California Los Angeles, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Silarus Therpeutics, Inc
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Professor Ganz will direct and coordinate the proposed studies and supervise the staff of the project. He will meet at least weekly with all the staff on this project, and will help perform data analysis and coordinate the preparation of manuscripts. He will also help supervise (b)(6) in studies of ERFE1 effects in healthy and thalassemic mice and (b)(6) in preparation and analysis of recombinant ERFE1 and its mutants. He will be primarily responsible for the coordination and analysis of studies of human samples. He is a founder of the company.
The role of erythroferrone in iron homeostasis and in iron-loading anemias
We discovered a bone marrow-derived hormone that regulates the supply of iron to the marrow. Although the hormone may aid the recovery of red blood cells after blood loss, in Cooley's anemia the excess of this hormone could cause fatal iron overload. Understanding how this hormone works could improve the treatment of this disease.
Filed on July 02, 2015.
Tell us what you know about Tomas Ganz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Tomas Ganz filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | $10,000 - $19,999 |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.